| Breakdown | TTM | Apr 2024 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2018 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.29M | 66.18M | 67.58M | 49.66M | 35.08M | 17.43M |
| Gross Profit | 17.20M | 42.93M | 42.77M | 31.66M | 22.87M | 11.53M |
| EBITDA | 12.18M | 11.10M | 11.07M | 12.95M | 8.49M | 3.40M |
| Net Income | 4.58M | 3.98M | 3.87M | 7.54M | 4.71M | 1.91M |
Balance Sheet | ||||||
| Total Assets | 93.83M | 88.23M | 84.99M | 68.92M | 48.70M | 26.55M |
| Cash, Cash Equivalents and Short-Term Investments | 1.51M | 1.31M | 2.71M | 5.11M | 3.84M | 2.49M |
| Total Debt | 26.07M | 21.98M | 22.74M | 11.44M | 5.64M | 4.10M |
| Total Liabilities | 42.38M | 38.56M | 43.70M | 33.13M | 21.93M | 9.46M |
| Stockholders Equity | 51.49M | 49.64M | 41.26M | 35.79M | 26.77M | 17.09M |
Cash Flow | ||||||
| Free Cash Flow | 7.42M | 7.42M | 6.33M | 11.26M | 9.22M | 2.21M |
| Operating Cash Flow | 8.76M | 9.30M | 7.74M | 13.10M | 10.26M | 3.22M |
| Investing Cash Flow | -8.64M | -9.03M | -22.38M | -12.77M | -5.02M | -7.79M |
| Financing Cash Flow | 355.00K | -205.00K | 12.10M | 982.00K | -6.58M | 5.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £65.51M | 3.57 | 22.93% | ― | 36.61% | ― | |
70 Neutral | £70.06M | 12.03 | 9.07% | ― | 7.36% | 31.93% | |
68 Neutral | £79.14M | 8.13 | 3.91% | 1.56% | 8.75% | -54.73% | |
67 Neutral | £210.75M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £208.38M | -4.02 | -31.21% | ― | -16.33% | -448.12% | |
54 Neutral | £91.30M | -24.70 | -5.90% | ― | -7.35% | -222.10% |